Fred Houghton

Head, Device Strategy and Evaluation PDT R&D at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

Fred Houghton's Colleagues at Takeda Pharmaceuticals (formerly Nycomed)
Celia Aguilar

ASISTENTE VTAS GOBIERNO

Contact Celia Aguilar

Ebla Khadra

Regulatory Affairs Specialist

Contact Ebla Khadra

Ahmed Bibars

Franchise Lead GI Speciality Care

Contact Ahmed Bibars

Bill Everett

Level V Neuroscience Sales Specialist

Contact Bill Everett

Andy Huang

Senior Director/ Head of Launch Excellence-Growth and Emerging Markets

Contact Andy Huang

Manoj Thakur

Associate Director, Statistics

Contact Manoj Thakur

Jasper Hill

Manufacturing Technician II

Contact Jasper Hill

View All Fred Houghton's Colleagues
Fred Houghton's Contact Details
HQ
224-554-6500
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Takeda Pharmaceuticals (formerly Nycomed)
Fred Houghton's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about Fred Houghton
Fred Houghton currently works for Takeda Pharmaceuticals (formerly Nycomed).
Fred Houghton's role at Takeda Pharmaceuticals (formerly Nycomed) is Head, Device Strategy and Evaluation PDT R&D.
Fred Houghton's email address is ***@takeda.com. To view Fred Houghton's full email address, please signup to ConnectPlex.
Fred Houghton works in the Major Drugs industry.
Fred Houghton's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Celia Aguilar, Ebla Khadra, Ahmed Bibars, Bill Everett, Andy Huang, Manoj Thakur, Jasper Hill and others.
Fred Houghton's phone number is 224-554-6500
See more information about Fred Houghton